These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31889487)

  • 1. Inhalation Delivery of Host Defense Peptides (HDP) using Nano- Formulation Strategies: A Pragmatic Approach for Therapy of Pulmonary Ailments.
    Adlakha S; Sharma A; Vaghasiya K; Ray E; Verma RK
    Curr Protein Pept Sci; 2020; 21(4):369-378. PubMed ID: 31889487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic mucus penetrating microspheres for efficient pulmonary delivery and enhanced efficacy of host defence peptide (HDP) in experimental tuberculosis.
    Sharma A; Vaghasiya K; Gupta P; Singh AK; Gupta UD; Verma RK
    J Control Release; 2020 Aug; 324():17-33. PubMed ID: 32418903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.
    Islan GA; Tornello PC; Abraham GA; Duran N; Castro GR
    Colloids Surf B Biointerfaces; 2016 Jul; 143():168-176. PubMed ID: 27003467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobactericidal activity of some micro-encapsulated synthetic Host Defense Peptides (HDP) by expediting the permeation of antibiotic: A new paradigm of drug delivery for tuberculosis.
    Sharma A; Vaghasiya K; Ray E; Gupta P; Kumar Singh A; Datta Gupta U; Kumar Verma R
    Int J Pharm; 2019 Mar; 558():231-241. PubMed ID: 30630076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches.
    Kłodzińska SN; Priemel PA; Rades T; Mørck Nielsen H
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27735846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria.
    Almaaytah A; Farajallah A; Abualhaijaa A; Al-Balas Q
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30004427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reclaiming hijacked phagosomes: Hybrid nano-in-micro encapsulated MIAP peptide ensures host directed therapy by specifically augmenting phagosome-maturation and apoptosis in TB infected macrophage cells.
    Sharma A; Vaghasiya K; Gupta P; Gupta UD; Verma RK
    Int J Pharm; 2018 Jan; 536(1):50-62. PubMed ID: 29180254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled Micro/Nanoparticulate Anticancer Drug Formulations: An Emerging Targeted Drug Delivery Strategy for Lung Cancers.
    Islam N; Richard D
    Curr Cancer Drug Targets; 2019; 19(3):162-178. PubMed ID: 29793407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics.
    Vaidya B; Kulkarni NS; Shukla SK; Parvathaneni V; Chauhan G; Damon JK; Sarode A; Garcia JV; Kunda N; Mitragotri S; Gupta V
    Int J Pharm; 2020 Mar; 577():118995. PubMed ID: 31935471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Antibacterial and Anti-inflammatory Activity of Chicken Cathelicidin-2 combined with Exogenous Surfactant for the Treatment of Cystic Fibrosis-Associated Pathogens.
    Banaschewski BJH; Baer B; Arsenault C; Jazey T; Veldhuizen EJA; Delport J; Gooyers T; Lewis JF; Haagsman HP; Veldhuizen RAW; Yamashita C
    Sci Rep; 2017 Nov; 7(1):15545. PubMed ID: 29138462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present Situation and Future Progress of Inhaled Lung Cancer Therapy: Necessity of Inhaled Formulations with Drug Delivery Functions.
    Okuda T; Okamoto H
    Chem Pharm Bull (Tokyo); 2020; 68(7):589-602. PubMed ID: 32611996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Era of Pulmonary Delivery of Nano-antimicrobial Therapeutics to Treat Chronic Pulmonary Infections.
    Merchant Z; Buckton G; Taylor KM; Stapleton P; Saleem IY; Zariwala MG; Somavarapu S
    Curr Pharm Des; 2016; 22(17):2577-98. PubMed ID: 26983671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-encapsulated HHC10 host defense peptide (HDP) reduces the growth of Escherichia coli via multimodal mechanisms.
    Sharma A; Vaghasiya K; Ray E; Verma RK
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S156-S165. PubMed ID: 30032649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic nanoparticles-based drug and gene delivery systems for the treatment of pulmonary diseases.
    El-Sherbiny IM; Elbaz NM; Sedki M; Elgammal A; Yacoub MH
    Nanomedicine (Lond); 2017 Feb; 12(4):387-402. PubMed ID: 28078950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients.
    Sans-Serramitjana E; Fusté E; Martínez-Garriga B; Merlos A; Pastor M; Pedraz JL; Esquisabel A; Bachiller D; Vinuesa T; Viñas M
    J Cyst Fibros; 2016 Sep; 15(5):611-8. PubMed ID: 26708265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very Short and Stable Lactoferricin-Derived Antimicrobial Peptides: Design Principles and Potential Uses.
    Svendsen JSM; Grant TM; Rennison D; Brimble MA; Svenson J
    Acc Chem Res; 2019 Mar; 52(3):749-759. PubMed ID: 30829472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilizing Organoid and Air-Liquid Interface Models as a Screening Method in the Development of New Host Defense Peptides.
    Choi KG; Wu BC; Lee AH; Baquir B; Hancock REW
    Front Cell Infect Microbiol; 2020; 10():228. PubMed ID: 32509598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming barriers in Pseudomonas aeruginosa lung infections: Engineered nanoparticles for local delivery of a cationic antimicrobial peptide.
    d'Angelo I; Casciaro B; Miro A; Quaglia F; Mangoni ML; Ungaro F
    Colloids Surf B Biointerfaces; 2015 Nov; 135():717-725. PubMed ID: 26340361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis.
    Lababidi N; Ofosu Kissi E; Elgaher WAM; Sigal V; Haupenthal J; Schwarz BC; Hirsch AKH; Rades T; Schneider M
    J Control Release; 2019 Nov; 314():62-71. PubMed ID: 31654686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging themes and therapeutic prospects for anti-infective peptides.
    Yount NY; Yeaman MR
    Annu Rev Pharmacol Toxicol; 2012; 52():337-60. PubMed ID: 22235859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.